|
[1]
|
陈斌专, 王妍春. 横纹肌溶解综合症的研究进展[J]. 分子影像学杂志, 2017, 40(4): 474-477.
|
|
[2]
|
陈茜, 吴岳桐, 赵华平, 孙钊, 刘建中, 曹国颖. 药源性横纹肌溶解症病例回顾及文献分析[J]. 临床药物治疗杂志, 2020, 18(5): 55-59.
|
|
[3]
|
Anagnostis, P., Paschou, S.A., Goulis, D.G., Athyros, V.G. and Karagiannis, A. (2018) Dietary Manage-ment of Dyslipidaemias. Is There Any Evidence for Cardiovascular Benefit? Maturitas, 108, 45-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
郭丽珍, 蒋建清. 脂必妥致横纹肌溶解及急性肾衰1例[J]. 药物流行病学杂志, 2002(6): 334.
|
|
[5]
|
李杰, 黄淑田. 血脂康致高龄病人横纹肌溶解症1例[J]. 中西医结合心脑血管病杂志, 2017, 15(7): 890-891.
|
|
[6]
|
Stahl, K., Rastelli, E. and Schoser, B. (2020) A Systematic Review on the Definition of Rhabdomyolysis. Journal of Neurology, 267, 877-882. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
周香珍, 林书发, 何书华. 红曲药学评价研究进展[J]. 中国现代中药, 2016, 18(7): 936-941.
|
|
[8]
|
郑云燕, 李应东. 红曲制剂治疗高脂血症的临床研究[J]. 中医临床研究, 2015, 7(9): 36-37.
|
|
[9]
|
何瑞, 徐志猛, 王来, 李萍, 闻晓东. 他汀相关肌肉症状的研究进展[J]. 药学进展, 2020, 44(4): 303-312.
|
|
[10]
|
Sacheck, J.M., Hyatt, J.P., Raffaello, A., et al. (2007) Rapid Disuse and Denervation Atrophy In-volve Transcriptional Changes Similar to Those of Muscle Wasting during Systemic Diseases. The FASEB Journal, 21, 140-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Petejova, N. and Martinek, A. (2014) Acute Kidney Injury Due to Rhabdomyolysis and Renal Replacement Therapy: A Critical Review. Critical Care, 18, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
唐吉刚, 曹秉振. 横纹肌溶解症及其研究进展[J]. 实用医药杂志, 2011, 28(10): 937-939.
|
|
[13]
|
Wallach-Kildemoes, H., Stovring, H., Holme Hansen, E., Howse, K. and Pétursson, H. (2016) Statin Prescribing According to Gender, Age and Indication: What about the Benefit-Risk Balance? Journal of Evaluation in Clinical Practice, 22, 235-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
赵宇红, 许丹焰, 赵水平, 黄艳红. 中药他汀类药物的研究进展[J]. 长治医学院学报, 2011, 25(1): 74-77.
|